The key reasons why EyePoint Pharmaceuticals Inc (EYPT) is -71.86% away from 52-week high?
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) established initial surge of 14.29% at $8.72, before settling in for the price of $7.63 at the close. Taking a
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) established initial surge of 14.29% at $8.72, before settling in for the price of $7.63 at the close. Taking a
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) started the day on Wednesday, with a price increase of 6.81% at $7.69, before settling in for the price of
On Friday, EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) was -8.45% drop from the session before settling in for the closing price of $9.11. A 52-week range
On Monday, EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) opened higher 5.08% from the last session, before settling in for the closing price of $8.26. Price fluctuations
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) open the trading on Tuesday, with great promise as it jumped 6.13% to $7.45, before settling in for the price
On Friday, EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) trading session started at the price of On Friday, that was -5.01% drop from the session before settling
On Friday, EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) was -0.28% drop from the session before settling in for the closing price of $7.12. A 52-week range
A new trading day began on Tuesday, with EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) stock price up 5.39% from the previous day of trading, before settling
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) flaunted slowness of -3.76% at $7.94, before settling in for the price of $8.25 at the close. Taking a more
A new trading day began on Friday, with EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) stock price up 6.74% from the previous day of trading, before settling
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.